Lakewood-Amedex Biotherapeutics (LABT) Financials: Revenue & Earnings
LABT$0.27-0.02 -5.63%
$472,852
Market Cap
—
P/E
—
Forward P/E
—
Score
Lakewood-Amedex Biotherapeutics (LABT) Financials: Revenue & Earnings
LABT price $0.27 -0.02 -5.63%
- Ticker
- LABT
- Price
- $0.27
- Change
- -0.02 -5.63%
- Market cap ?
- $472,852
- Beta ?
- -4.76
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
LABT fair value $193.90. Price $0.27. Price is 100% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-12 | — | -0.81 | — | — |
| 2026-08-13 | -2.75 | -2.66 | — | — |
| 2026-05-22 | -1.32 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-04-24 | Tucker Joseph Edward | Buy | 33.78K | $10.00 | 337.84K |
| 2026-04-24 | Tucker Joseph Edward | Other | 0 | — | — |
| 2026-04-17 | DeRoma Leonard James | Other | 0 | — | — |
| 2026-04-17 | Balzer Thomas | Other | 0 | — | — |
| 2026-04-17 | Cooper Kelvin | Other | 0 | — | — |
| 2026-04-17 | Ceccacci Peter | Other | 0 | — | — |
| 2025-11-01 | Cooper Kelvin | Other | 13.51K | $2.78 | 37.57K |
| 2025-07-02 | Balzer Thomas | Other | 168.92K | $2.31 | 390.20K |
| 2025-07-02 | Cooper Kelvin | Other | 202.70K | $2.31 | 468.24K |
| 2025-07-02 | Ceccacci Peter | Other | 202.70K | $2.31 | 468.24K |
| 2025-03-14 | Balzer Thomas | Other | 46.12K | $2.13 | 98.22K |
| 2025-03-14 | Ceccacci Peter | Other | 29.56K | $2.13 | 62.96K |
| 2024-08-01 | Cooper Kelvin | Other | 72.47K | $2.13 | 154.35K |
| 2022-07-12 | DeRoma Leonard James | Other | 8.45K | $2.13 | 17.99K |
| 2022-03-01 | Ceccacci Peter | Other | 33.78K | $2.78 | 93.92K |
| 2021-07-12 | DeRoma Leonard James | Other | 8.45K | $2.78 | 23.48K |
| 2020-07-12 | DeRoma Leonard James | Other | 8.45K | $2.37 | 20.02K |
| 2018-01-12 | DeRoma Leonard James | Other | 33.78K | $5.92 | 200.00K |
Institutional holders
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| No data yet. | ||||
Earnings and financials
Lakewood-Amedex Biotherapeutics, Inc. (LABT) trades at $0.27, with a market cap of $472,852 and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn